5 Best Biotech Stocks to Buy According to Cathie Wood
Number of Hedge Fund Holders: 29
Intellia Therapeutics, Inc. (NASDAQ: NTLA) is a Massachusetts-based biotech firm founded in 2014. It is ranked fifth on our list of 10 best biotech stocks to buy according to Cathie Wood. The company stock has offered investors more than 258% returns in the past twelve months. The investment in Intellia represents 1.53% of ARK Investment’s portfolio. The company focuses on the development and marketing of products made using a CRISPR gene-editing system. The system was pioneered by Jennifer Doudna and Virginijus Šikšnys.
Intellia Therapeutics, Inc. (NASDAQ: NTLA) reported earnings per share of -$0.69 for the first quarter of 2021 on May 6, missing market estimates by $0.04. The revenue for the period was close to $6.5 million, down 50% compared to last year.